Patents by Inventor Pierre Ray

Pierre Ray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Processor with a configurable distribution of privileged resources and exceptions between protection rings
    Patent number: 11995218
    Abstract: A processor having a plurality of protection rings and comprising a protection ring management system in which the attributions of exceptions or privileged resources to protection rings are defined by a programmable table.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: May 28, 2024
    Assignee: Kalray
    Inventors: Pierre Guironnet De Massas, Vincent Ray, Benoit Dupont De Dinechin
  • Use of La1-like peptide isolated from maurus palmatus venom as an activator of sperm motility in mammals
    Patent number: 10729745
    Abstract: The invention relates to a La-1-like peptide agent that increases sperm motility. It is non-toxic and it may be used to treat male infertility in humans, and also to increase fertility in animals. It may be used in artificial reproductive techniques such as in vitro fertilisation (IVF), including intra-cytoplasmic sperm injection (ICSI). The La-1 like peptide agent may also be used in artificial insemination techniques such as intra-cytoplasmic uterine injection (IUI).
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: August 4, 2020
    Assignee: IMV TECHNOLOGIES
    Inventors: Christophe Arnoult, Eric Schmitt, Guillaume Martinez, Pierre Ray
  • USE OF LA1-LIKE PEPTIDE ISOLATED FROM MAURUS PALMATUS VENOM AS AN ACTIVATOR OF SPERM MOTILITY IN MAMMALS
    Publication number: 20190151412
    Abstract: The invention relates to a La-1-like peptide agent that increases sperm motility. It is non-toxic and it may be used to treat male infertility in humans, and also to increase fertility in animals. It may be used in artificial reproductive techniques such as in vitro fertilisation (IVF), including intra-cytoplasmic sperm injection (ICSI). The La-1 like peptide agent may also be used in artificial insemination techniques such as intra-cytoplasmic uterine injection (IUI).
    Type: Application
    Filed: June 1, 2017
    Publication date: May 23, 2019
    Inventors: Christophe ARNOULT, Eric SCHMITT, Guillaume MARTINEZ, Pierre RAY
  • HUMAN FERTILITY TEST USING DPY19L2
    Publication number: 20120283126
    Abstract: The present patent application concerns a method for diagnosing infertility related to the DPY19L2 protein, in a male human subject, and a method for treating said subject with a view to restoring fertility. The present invention also concerns the use of molecules inhibiting the action of the DPY19L2 polypeptide in a wild-type carrier male subject, for example of anti-DPY19L2 interfering nucleic acid type selectively inhibiting the expression of the DPY19L2 polypeptide.
    Type: Application
    Filed: November 10, 2010
    Publication date: November 8, 2012
    Applicant: UNIVERSITE JOSEPH FOURIER (GRENOBLE 1)
    Inventors: Pierre Ray, Christophe Arnoult